2020
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2
Wyllie AL, Fournier J, Casanovas-Massana A, Campbell M, Tokuyama M, Vijayakumar P, Warren JL, Geng B, Muenker MC, Moore AJ, Vogels CBF, Petrone ME, Ott IM, Lu P, Venkataraman A, Lu-Culligan A, Klein J, Earnest R, Simonov M, Datta R, Handoko R, Naushad N, Sewanan LR, Valdez J, White EB, Lapidus S, Kalinich CC, Jiang X, Kim DJ, Kudo E, Linehan M, Mao T, Moriyama M, Oh JE, Park A, Silva J, Song E, Takahashi T, Taura M, Weizman OE, Wong P, Yang Y, Bermejo S, Odio CD, Omer SB, Dela Cruz CS, Farhadian S, Martinello RA, Iwasaki A, Grubaugh ND, Ko AI. Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2. New England Journal Of Medicine 2020, 383: 1283-1286. PMID: 32857487, PMCID: PMC7484747, DOI: 10.1056/nejmc2016359.Peer-Reviewed Original Research
2015
Are current screening protocols for chronic hepatitis B virus infection adequate?
Mortensen E, Kamali A, Schirmer PL, Lucero-Obusan C, Winston CA, Oda G, Winters MA, Durfee J, Martinello RA, Davey VJ, Holodniy M. Are current screening protocols for chronic hepatitis B virus infection adequate? Diagnostic Microbiology And Infectious Disease 2015, 85: 159-167. PMID: 27009896, DOI: 10.1016/j.diagmicrobio.2015.12.005.Peer-Reviewed Original ResearchConceptsOccult HBV infectionHBV infectionHBV DNAOBI prevalenceChronic hepatitis B virus infectionHepatitis B virus infectionEnzyme immunoassayHBsAg-negative patientsInitiation of immunosuppressionLook-back investigationChronic HBV infectionSerum HBV DNAB virus infectionHBV DNA testingCurrent screening protocolsPatient blood samplesHBsAg enzyme immunoassayHBV testingOBI rateCohort patientsHBsAg testingAntigen testingHBV screeningInfection screeningHBV core